by Susan Rahimi
Published in The Lancet Respiratory Medicine, 08 March 2019. DOI: https://doi.org/10.1016/S2213-2600(19)30076-1
"In February, 2019, the American Thoracic Society (ATS) released new guidance for home oxygen therapy in children with chronic respiratory conditions. These guidelines, drawn up by a panel of 22 experts in paediatric and neonatal medicine, respiratory therapy, and nursing and population health, as well as parents, aimed to define hypoxaemia in children and produce recommendations for supplementary home oxygen therapy in paediatric lung and pulmonary vascular diseases. Long-term oxygen therapy is increasingly used in both paediatric and adult patients. In June, 2007, 4% of all patients (3136 children) using long-term oxygen therapy in England and Wales were younger than 17 years. The most common diagnosis requiring long-term oxygen therapy is chronic neonatal lung disease. In these infants, peripheral capillary oxygen saturation (SpO2) of less than 90% is associated with an increased risk of apparent life-threatening events, whereas an SpO2 of 93% or higher is not. With increasing survival rates in premature babies, the need for long-term oxygen therapy has also increased and will continue to do so. Other conditions that require supplementary oxygen therapy are wide ranging and include pulmonary hypertension, intrapulmonary shunting, interstitial lung disease, and cystic fibrosis." Access the full article here.